Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Shohei Shiota"'
Autor:
Kazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, Hidenori Toyoda, Toshifumi Tada, Kunihiko Tsuji, Toru Ishikawa, Takeshi Hatanaka, Ei Itobayashi, Koichi Takaguchi, Akemi Tsutsui, Atsushi Naganuma, Satoshi Yasuda, Satoru Kakizaki, Akiko Wakuta, Shohei Shiota, Masatoshi Kudo, Takashi Kumada
Publikováno v:
Journal of Liver Cancer, Vol 24, Iss 1, Pp 71-80 (2024)
Background/Aim The aim of this study was to compare the therapeutic efficacy of ablation and surgery in solitary hepatocellular carcinoma (HCC) measuring ≤5 cm with a large HCC cohort database. Methods The study included consecutive 2,067 patients
Externí odkaz:
https://doaj.org/article/47df0bb2c3e54b1baf0ddae5d004bf55
Autor:
Kazuya Kariyama, Miwa Kawanaka, Kazuhiro Nouso, Akiko Wakuta, Shohei Shiota, Akemi Kurisu, Aya Sugiyama, Tomoyuki Akita, Takashi Kumada, Junko Tanaka, the Real‐Life Practice Experts for HCC (RELPEC) Study Group
Publikováno v:
JGH Open, Vol 8, Iss 7, Pp n/a-n/a (2024)
Abstract Background and Aim We conducted a study using the Fibrosis‐3 (FIB‐3) index, which is the established age‐independent index of fibrosis in nonviral liver disease and addresses the limitations of the FIB‐4 index in older age group, to
Externí odkaz:
https://doaj.org/article/79e9a833ed924293ae0f419843422eec
Autor:
Kazuhiro Nouso, Shohei Shiota, Rio Fujita, Akiko Wakuta, Kazuya Kariyama, Atsushi Hiraoka, Masanori Atsukawa, Joji Tani, Toshifumi Tada, Shinichiro Nakamura, Kazuto Tajiri, Masaki Kaibori, Masashi Hirooka, Ei Itobayashi, Satoru Kakizaki, Atsushi Naganuma, Toru Ishikawa, Takeshi Hatanaka, Shinya Fukunishi, Kunihiko Tsuji, Kazuhito Kawata, Koichi Takaguchi, Akemi Tsutsui, Chikara Ogawa, Hironori Ochi, Yutaka Yata, Hidekatsu Kuroda, Hiroko Iijima, Tomomitsu Matono, Noritomo Shimada, Satoshi Yasuda, Hidenori Toyoda, Takashi Kumada, the Real‐life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan)
Publikováno v:
Cancer Medicine, Vol 12, Iss 17, Pp 17849-17855 (2023)
Abstract Aim Multiple studies have revealed the correlation between gut microbiome and the response to checkpoint inhibitors (CPIs) in patients with cancer, and oral administration of butyrate‐producing enterobacteria has been reported to enhance t
Externí odkaz:
https://doaj.org/article/63364b06136f40709acc82310c3985ee
Autor:
Kazuya Kariyama, Miwa Kawanaka, Kazuhiro Nouso, Atsushi Hiraoka, Hidenori Toyoda, Toshifumi Tada, Toru Ishikawa, Akiko Wakuta, Nozomi Miyake, Shiho Murakami, Shohei Shiota, Takashi Kumada
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 6, Pp 1108-1113 (2022)
Background and Aims: The Fibrosis-4 (FIB-4) index has been used to predict liver fibrosis in various liver diseases, including nonalcoholic fatty liver disease (NAFLD). Because the FIB-4 formula uses age, different cutoff values may be required for d
Externí odkaz:
https://doaj.org/article/211601897a5f448f99b4c03d51620152
Autor:
Hidenori Toyoda, Satoshi Yasuda, Shohei Shiota, Shohei Chatani, Ryota Tsukii, Hirofumi Kitagawa, Tomohisa Fukushima, Shohei Urasaki, Takashi Kumada
Publikováno v:
JGH Open, Vol 5, Iss 9, Pp 1041-1046 (2021)
Abstract Background and Aim Hepatic angiography procedures such as transarterial chemoembolization (TACE) are essential procedures for managing patients with hepatocellular carcinoma (HCC), and are usually performed with femoral access. However, femo
Externí odkaz:
https://doaj.org/article/03361f0bc6554fc4bf67bd7a0e69a74a
Autor:
Kazuya Kariyama, Atsushi Hiraoka, Takashi Kumada, Satoshi Yasuda, Hidenori Toyoda, Kunihiko Tsuji, Takeshi Hatanaka, Satoru Kakizaki, Atsushi Naganuma, Toshifumi Tada, Koichi Takaguchi, Ei Itobayashi, Toru Ishikawa, Noritomo Shimada, Akemi Tsutsui, Takuya Nagano, Michitaka Imai, Shinichiro Nakamura, Akiko Wakuta, Nozomi Miyake, Shohei Shiota, Kazuhiro Nouso
Publikováno v:
Journal of Gastroenterology. 57:581-586
The albumin-bilirubin (ALBI) score and the modified ALBI (mALBI) grade are known useful prognostic factors for patients with hepatocellular carcinoma (HCC) treated with lenvatinib (LEN-HCC). However, the ALBI score requires complicated logarithmic ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5d7bab70e31bfee170282d1bc14f77e
https://doi.org/10.1007/s00535-022-01883-7
https://doi.org/10.1007/s00535-022-01883-7
Publikováno v:
European Journal of Gastroenterology & Hepatology. 34:693-697
Patients with chronic hepatitis C virus (HCV) infection who achieve sustained virologic response (SVR) to anti-HCV therapy, that is the eradication of HCV, are recommended to continue regular hospital visits for the surveillance of hepatocellular car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::679588dee4cc44d0a574e5368ce99ff4
https://doi.org/10.1097/meg.0000000000002358
https://doi.org/10.1097/meg.0000000000002358
Publikováno v:
Hepatology Research. 52:128-132
Non-hypervascular hypointense nodules (NHHNs) on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (EOB-MRI) have a high likelihood of hypervascularization progressing to typical hypervascular hepatocellu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::097d767e3cbd2b11c3f0c74463566c3c
https://doi.org/10.1111/hepr.13707
https://doi.org/10.1111/hepr.13707
Autor:
Satoshi Yasuda, Ryota Tsukii, Hirofumi Kitagawa, Hidenori Toyoda, Shohei Shiota, Shohei Urasaki, Shohei Chatani, Tomohisa Fukushima, Takashi Kumada
Publikováno v:
JGH Open, Vol 5, Iss 9, Pp 1041-1046 (2021)
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
Background and Aim Hepatic angiography procedures such as transarterial chemoembolization (TACE) are essential procedures for managing patients with hepatocellular carcinoma (HCC), and are usually performed with femoral access. However, femoral acces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e0258bf6044f67da734e622ecd4fbea
https://doi.org/10.1002/jgh3.12628
https://doi.org/10.1002/jgh3.12628
Autor:
Yuji Kaneoka, Takashi Kumada, Junko Tanaka, Yasuhiro Sone, Atsuyuki Maeda, Hidenori Toyoda, Shohei Shiota, Satoshi Yasuda
Publikováno v:
Alimentary Pharmacology & Therapeutics. 53:1309-1316
BACKGROUND Identification of risk factors for the development of hepatocellular carcinoma (HCC) after a sustained virologic response (SVR) in patients with chronic hepatitis C virus (HCV) infection is urgently needed for HCC surveillance. AIMS To eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a02d36af79e7f9a8a4e337b3a6c8451
https://doi.org/10.1111/apt.16382
https://doi.org/10.1111/apt.16382